Skip to content

Creation of a medication delivery model to improve the treatment of patients with Mental Illness

Development of a medication dispensing model to improve the degree of adherence in Psychiatric Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3zj4hgf
Enrollment
Unknown
Registered
2023-02-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence

Interventions

This is a single-blind randomized controlled clinical study with two arms, intervention group and control group. All participants were randomly assigned to either the intervention group or the control

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: individuals aged 18 years or older; active medical record in the health unit under study; diagnosis of mental disorder in pharmacological treatment; ability to self-administer their medications, being self-declared by the patient

Exclusion criteria

Exclusion criteria: individuals who were unable to understand and answer the questions of the instruments used for data collection

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: It is expected to find in the intervention group a significant decrease in the scores of predictors of adherence, that is, improvement in the predictors of adherence of patients from baseline to follow-up in relation to the control group, in the period of 90 days, verified through the Scale of Evaluation of Factors Related to Adherence to Pharmacological Treatment in Psychiatric Patients, between the pre and post intervention periods;Outcome found 1: A decrease in the scores of predictors of adherence was observed in the intervention group, that is, improvement in the predictors of adherence of patients from baseline to follow-up (10.7 [standard deviation equal to 6, 1] versus 4.2 [standard deviation equal to 3.6]; p less than 0.001) and in the control group, there was no difference in scores of predictors of adherence at baseline and follow-up (9.5 [deviation standard equal to 5.9] versus 9.5 [standard deviation equal to 6.8]; p=0.925), in the period of 90 days, verified through the Scale of Evaluation of Factors Related to Adherence to Pharmacological Treatment in Psychiatric Patients , between the pre and post intervention periods.

Secondary

MeasureTime frame
Expected outcome 2: It is expected to find in the intervention group a significant increase in the scores of the level of knowledge, from the baseline to the follow-up, in relation to the control group, in the period of 90 days, verified by means of an instrument that evaluates the level of knowledge of patients in relation to prescribed drugs, between the pre and post intervention periods.;Outcome found 2: In the intervention group, an increase in the scores of patients' level of knowledge was observed, from baseline to follow-up (6.21 [standard deviation: 2.07] versus 9.61 [standard deviation: 1. 35]; p<0.001) and in the control group there was no difference in the scores of the level of knowledge, from baseline to follow-up (6.03 [standard deviation: 2.46] versus 6.06 [standard deviation=2 ,69]; p=0.909), in the period of 90 days, verified by means of an instrument that evaluates the level of knowledge of the patients in relation to the prescribed medications, between the pre and post intervention periods.

Countries

Brazil

Contacts

Public ContactNúbia Carvalho

Universidade Federal de Goiás

nubiaburgo@hotmail.com+556232096038

Outcome results

None listed

Source: REBEC (via WHO ICTRP)